Search Results - "Neuman, Rachel"

Long-Term Follow-Up of 23 Operational Tolerant Liver Transplant Recipients by TRYPHONOPOULOS, Panagiotis, RUIZ, Phillip, SELVAGGI, Gennaro, TZAKIS, Andreas G, WEPPLER, Debbie, NISHIDA, Seigo, LEVI, David M, MOON, Jang, TEKIN, Akin, VELEZ, Madeline, RACHEL NEUMAN, Danielle, ISLAND, Eddie

“…This is a follow-up of a withdrawal study that we previously performed on 104 liver transplant patients in which immunosuppression was gradually withdrawn over…”
Get full text

A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas by Moskowitz, Alison J., Ghione, Paola, Jacobsen, Eric, Ruan, Jia, Schatz, Jonathan H., Noor, Sarah, Myskowski, Patricia, Vardhana, Santosha, Ganesan, Nivetha, Hancock, Helen, Davey, Theresa, Perez, Leslie, Ryu, Sunyoung, Santarosa, Alayna, Dowd, Jack, Obadi, Obadi, Pomerantz, Lauren, Yi, Nancy, Sohail, Samia, Galasso, Natasha, Neuman, Rachel, Liotta, Brielle, Blouin, William, Baik, Jeeyeon, Geyer, Mark B., Noy, Ariela, Straus, David, Kumar, Priyadarshini, Dogan, Ahmet, Hollmann, Travis, Drill, Esther, Rademaker, Jurgen, Schoder, Heiko, Inghirami, Giorgio, Weinstock, David M., Horwitz, Steven M.

“…Signaling through JAK1 and/or JAK2 is common among tumor and nontumor cells within peripheral T-cell lymphoma (PTCL). No oral therapies are approved for PTCL,…”
Get full text

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma by Moskowitz, Alison J, Shah, Gunjan, Schöder, Heiko, Ganesan, Nivetha, Drill, Esther, Hancock, Helen, Davey, Theresa, Perez, Leslie, Ryu, Sunyoung, Sohail, Samia, Santarosa, Alayna, Galasso, Natasha, Neuman, Rachel, Liotta, Brielle, Blouin, William, Kumar, Anita, Lahoud, Oscar, Batlevi, Connie L, Hamlin, Paul, Straus, David J, Rodriguez-Rivera, Ildefonso, Owens, Colette, Caron, Philip, Intlekofer, Andrew M, Hamilton, Audrey, Horwitz, Steven M, Falchi, Lorenzo, Joffe, Erel, Johnson, William, Lee, Christina, Palomba, M Lia, Noy, Ariela, Matasar, Matthew J, Pongas, Georgios, Salles, Gilles, Vardhana, Santosha, Sanin, Beatriz Wills, von Keudell, Gottfried, Yahalom, Joachim, Dogan, Ahmet, Zelenetz, Andrew D, Moskowitz, Craig H

“…We conducted a phase II study evaluating pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin (pembro-GVD) as second-line therapy for…”
Get full text

TP53 Mutations Identify High-Risk Peripheral T-Cell Lymphoma Patients Treated with CHOP-Based Chemotherapy by Johnson, William T., Ganesan, Nivetha, Epstein-Peterson, Zachary D., Maccaro, Catherine, Galasso, Natasha, Sauter, Craig S., Neuman, Rachel, Khan, Niloufer, Moskowitz, Alison J., Dogan, Ahmet, Horwitz, Steven M.

“…Introduction Mutational profiling in peripheral T-cell lymphoma (PTCL) is increasingly used to aid in diagnosis (Wang. Blood 2015), predicting response…”
Get full text

Peripheral Blood Gene Expression Analysis in Intestinal Transplantation: A Feasibility Study for Detecting Novel Candidate Biomarkers of Graft Rejection by ANDREEV, Victor P, TRYPHONOPOULOS, Panagiotis, LEVI, David M, TZAKIS, Andreas G, RUIZ, Phillip, BLOMBERG, Bonnie B, TSINOREMAS, Nick, WEPPLER, Debbie, NEUMAN, Danielle-Rachel, VOLSKY, Alex, NISHIDA, Seigo, TEKIN, Akin, SELVAGGI, Gennaro

“…We investigated the putative candidate biomarkers of graft rejection in peripheral blood of intestinal transplant patients. Peripheral blood gene expression…”
Get full text

Phase II Study of Pembrolizumab Plus GVD As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma by Moskowitz, Alison J., Shah, Gunjan, Schöder, Heiko, Ganesan, Nivetha, Hancock, Helen, Davey, Theresa, Sohail, Samia, Santarosa, Alayna, Pomerantz, Lauren, Jarjies, Christine, Galasso, Natasha, Neuman, Rachel, Kumar, Anita, Lahoud, Oscar B, Batlevi, Connie Lee, Hamlin, Paul A., Straus, David J., Rodriguez-Rivera, Ildefonso, Owens, Colette, Caron, Philip, Intlekofer, Andrew M., Hamilton, Audrey, Horwitz, Steven M., Falchi, Lorenzo, Joffe, Erel, Palomba, Maria Lia, Noy, Ariela, Matasar, Matthew J, Pongas, Georgios, Vardhana, Santosha, von Keudell, Gottfried R., Yahalom, Joachim, Zelenetz, Andrew D, Moskowitz, Craig H.

“…Introduction: The standard approach for relapsed or refractory (RR) classical Hodgkin lymphoma (cHL) following front-line treatment failure is second line…”
Get full text

Promoting resilience in at-risk youth: The development of a therapeutic model by Neuman Guides, Rachel

“…Resilience has been investigated and observed in many diverse, at-risk populations. A significant amount of the research has focused on investigations of the…”
Get full text

Promoting resilience in at -risk youth: The development of a therapeutic model by Neuman Guides, Rachel

“…Resilience has been investigated and observed in many diverse, at-risk populations. A significant amount of the research has focused on investigations of the…”
Get full text